The Future of Genetics

We just completed our 400 patient accment trial, a multi center trial in partnership with a Cleveland Clinic. So we should have that trials read out in early 2023. In addition to the clinicals, we'll be launching commercially this year. And so the installed base for cardiovascular flux is, uh, is expected to double, um, in 2023. We're really focused on at this point delivering cardio flux and dedicating our time and energy to making our users as successful as they can possibly be.